Miss, what is driving the stock up is yesterday's and today's over average call option volume due to increased demand and confidence in stock. Yesterday was a record, 12,500 calls vs the daily average of 5,000. I expect more investors to become emboldened and buy in in the next few weeks before April 1 and April 15. I think we will see $7 @ sh or maybe $8 before Adcom. I would be suspect of approval but the clinical trails effacy is holding up and approval should put us over $15 @ sh, then $20 with partner announcement, and $27 with EU approval. All this should happen in the next few months.